Investigating myeloid cells' role during cancer therapy is critical to developing novel strategies, as they shape the tumor microenvironment and modulate anti-tumor immune responses. Using single-cell RNA sequencing (scRNAseq), we examined the impact of the immunostimulant N-dihydrogalactochitosan (GC) on myeloid cells within MMTV-PyMT tumors. We discovered unique myeloid cell clusters with varied responses to GC, showing increased proportions of certain cell types, such as G-MDSC, monocytes, and DCs. Importantly, we observed significant upregulation of STING signaling-associated genes, indicative of conventional STING signaling and canonical NFkB signaling activation. Furthermore, our analysis showed an upregulation of proinflammatory cytokines in cDCs, and a significant reduction in M2-like macrophages post-GC treatment. This supports GC's potent immunostimulatory properties, activating key cells within the tumor microenvironment to enhance antitumor immunity.
Access to the requested content is limited to institutions that have purchased or subscribe to SPIE eBooks.
You are receiving this notice because your organization may not have SPIE eBooks access.*
*Shibboleth/Open Athens users─please
sign in
to access your institution's subscriptions.
To obtain this item, you may purchase the complete book in print or electronic format on
SPIE.org.
INSTITUTIONAL Select your institution to access the SPIE Digital Library.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.